Pharmacology & ToxicologybioRxiv
Variability in Human Drug Metabolizing Cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 Activities Caused by Genetic Variations in Cytochrome P450 Oxidoreductase
M. N. R. Velazques, S. Parween, S. S. Udhane, A. V. Pandey
This study identifies POR variants affecting CYP2C9, CYP2C19, and CYP3A5 activities and shows their impact on drug metabolism.
DOI 10.1016/j.bbrc.2019.05.127